FDA Inspection
Sun Pharmaceutical Industries LtdSun Pharmaceutical Industries Ltd – FDA Inspection, Feb 6, 2026
Record Details
This FDA Inspection record concerns Sun Pharmaceutical Industries Ltd, with an inspection on February 6, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 1fae2324-f12f-48df-ab29-598590885889
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1304060
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sun Pharmaceutical Industries Ltd
11| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2026 | Not classified | Office of Inspections and Investigations | |
| September 26, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 29, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 16, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sun Pharmaceutical Industries Ltd
- FDA Inspection 1330976 - 2026-07-24
- FDA Inspection 1072207 - 2018-09-26
- FDA Inspection 1068593 - 2018-08-29
- FDA Inspection 1051162 - 2018-03-07
- FDA Inspection 1048050 - 2018-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.